3902 — Medical Data Vision Co Income Statement
0.000.00%
Last trade - 00:00- ¥16bn
- ¥15bn
- ¥6bn
- 76
- 15
- 39
- 38
Annual income statement for Medical Data Vision Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4,580 | 5,672 | 6,105 | 6,419 | 5,907 |
| Cost of Revenue | |||||
| Gross Profit | 3,882 | 4,644 | 5,030 | 5,031 | 4,331 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,505 | 4,079 | 4,722 | 4,781 | 6,121 |
| Operating Profit | 1,075 | 1,594 | 1,382 | 1,638 | -214 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,077 | 1,592 | 1,427 | 1,568 | -727 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 703 | 1,100 | 857 | 954 | -803 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 700 | 1,087 | 871 | 979 | -791 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 700 | 1,087 | 870 | 979 | -791 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 20.7 | 29.6 | 31 | 29.1 | -16.4 |
| Dividends per Share |